You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 2, 2024

CLINICAL TRIALS PROFILE FOR TECARTUS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TECARTUS

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03642626 ↗ MT2017-45: CAR-T Cell Therapy for Heme Malignancies Recruiting Masonic Cancer Center, University of Minnesota 2018-12-18 This is a phase II study of FDA-approved CAR-T products for patients with hematologic malignancies. Patients will be assigned to Arm A and B based on age and diagnosis. Overall remission rate, safety events and other endpoints will be calculated for Arm A and B separately.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TECARTUS

Condition Name

Condition Name for TECARTUS
Intervention Trials
Acute Lymphoblastic Leukemia 1
Large B-cell Lymphoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TECARTUS
Intervention Trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 1
Lymphoma, B-Cell 1
Leukemia, Lymphoid 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TECARTUS

Trials by Country

Trials by Country for TECARTUS
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TECARTUS
Location Trials
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TECARTUS

Clinical Trial Phase

Clinical Trial Phase for TECARTUS
Clinical Trial Phase Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TECARTUS
Clinical Trial Phase Trials
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TECARTUS

Sponsor Name

Sponsor Name for TECARTUS
Sponsor Trials
Masonic Cancer Center, University of Minnesota 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TECARTUS
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.